-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
href="" target="_blank" rel="noopener"> May 28, according to the latest news on the adverse reaction report of the immunization program on the official website of the China Center for Disease Control and Prevention , from December 15, 2020 to April 30, 2021, 31 provinces, municipalities, autonomous regions, and Xinjiang Production and Construction Corps reported vaccination against the new crown virus.
Immunization prevention
Among the adverse reactions, 26,078 were general reactions, accounting for 82.
Blood vessel
The Chinese Center for Disease Control and Prevention has released a detailed interpretation of the monitoring information on adverse reactions of the new crown vaccination nationwide .
Interpretation of the general reaction and abnormal reaction rate of China's new coronavirus vaccine are lower than the average reported level of other types of vaccines in China in 2019.
About 40% of subjective symptoms such as dizziness, fatigue, or nausea are reported in general reactions.
Most of them also have systemic symptoms such as pain, redness and swelling at the injection site, fever, headache, nausea, diarrhea, fatigue, and limb pain.
New Coronary Pneumonia Infection
China’s Disease Control and Prevention stated that China has started mass population vaccination on December 15, 2020.
Inactivated vaccines, adenovirus vector vaccines (type 5 adenovirus vectors), recombinant subunit vaccines (CHO cells) and other vaccines with different technical routes have been used in emergency domestically or approved for marketing with conditions.
Inactivated vaccines, adenovirus vector vaccines (type 5 adenovirus vectors), recombinant subunit vaccines (CHO cells) and other vaccines with different technical routes have been used in emergency domestically or approved for marketing with conditions.
Leave a message here